CLASS II Drug recall · Reported 24 Oct 2018 · FDA Enforcement Report
CeraVe Healing Lip Balm/SPF 30 (avobenzone recalled
Product Quest Manufacturing is recalling CeraVe Healing Lip Balm/SPF 30 (avobenzone 3%, dimethicone 1%, homosalate 10%, octisalate, distributed nationwide in the US. The recall was initiated on 3 Aug 2018 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0071-2019
- FDA event ID
- 80750
- Recalling firm
- Product Quest Manufacturing, Daytona Beach, FL
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 3 Aug 2018
- FDA classified
- 16 Oct 2018
- Reported
- 24 Oct 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Drug class
- Sunscreen & Personal Care
Timeline
| 3 Aug 2018 | Recall initiated by company | |
| 16 Oct 2018 | Classified by FDA | +74 days |
| 24 Oct 2018 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Microbial Contamination of Non-Sterile Products: Failed microbiological testing for Staphalococcus aureus.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
CeraVe Healing Lip Balm/SPF 30 (avobenzone 3%, dimethicone 1%, homosalate 10%, octisalate 5%, octocrylene 10%, Net Wt. 0.15 oz. (4.25 g) stick, CeraVe LLC., New York, NY 10001, UPC 3 01872 49201 7.
Where it was distributed
Nationwide in the USA
Questions about this recall
Is CeraVe Healing Lip Balm/SPF 30 (avobenzone 3%, dimethicone 1%, homosalate 10%, octisalate recalled?
Yes. Product Quest Manufacturing recalled CeraVe Healing Lip Balm/SPF 30 (avobenzone 3%, dimethicone 1%, homosalate 10%, octisalate on 3 Aug 2018. The recall is Class II and its status is Terminated. Recall number D-0071-2019.
Why was it recalled?
Microbial Contamination of Non-Sterile Products: Failed microbiological testing for Staphalococcus aureus.
Which lots are affected?
Lot: PSP85W/172792H
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Product Quest Manufacturing
All 54| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | CVS Health, Saline Nasal Spray recalled by Product Quest Manufacturing | Product Quest Manufacturing | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Rhinall (phenylephrine hydrochloride) Nasal Decongestant recalled | Product Quest Manufacturing | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | CVS Health, Original Strength recalled by Product Quest Manufacturing | Product Quest Manufacturing | Potency & Assay | Nationwide |
| Drug | CLASS II | Rite Aid Pharmacy, nasal relief NO Drip Pump Spray nasal recalled | Product Quest Manufacturing | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Premier Value, Sterile Saline Nasal Mist recalled | Product Quest Manufacturing | Sterility | Nationwide |